Page last updated: 2024-08-23

dermatan sulfate and Respiratory Distress Syndrome

dermatan sulfate has been researched along with Respiratory Distress Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hagiwara, S; Hidaka, S; Hishiyama, S; Iwasaka, H; Noguchi, T	1

Other Studies

1 other study(ies) available for dermatan sulfate and Respiratory Distress Syndrome

Article	Year
Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Critical care (London, England), 2008, Volume: 12, Issue:2 Topics: Animals; Chondroitin Sulfates; Dermatan Sulfate; Endotoxins; Heparitin Sulfate; HMGB1 Protein; I-kappa B Proteins; Interleukin-10; Interleukin-6; Male; Mice; NF-kappa B; Rats; Rats, Wistar; Respiratory Distress Syndrome; Survival Rate; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha	2008

Article

Year

Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats.

Critical care (London, England), 2008, Volume: 12, Issue:2

Topics: Animals; Chondroitin Sulfates; Dermatan Sulfate; Endotoxins; Heparitin Sulfate; HMGB1 Protein; I-kappa B Proteins; Interleukin-10; Interleukin-6; Male; Mice; NF-kappa B; Rats; Rats, Wistar; Respiratory Distress Syndrome; Survival Rate; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2008